NCT01206647 - Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Metformin and Saxagliptin

Metformin 500mg/daily titrated to 2000mg/d in 4 Weeks (continued for 20 weeks) Saxagliptin 5 mg daily over complete trial

Trial Locations (7)

ikfe Studiencenter Potsdam GmbH, Potsdam

Diabetologische Schwerpunktpraxis Dr. Lorra / Dr. Bonnermann, Bochum

Gemeinschaftspraxis Partner der Gesundheit, Essen

Zentrum für Diabetes und Gefäßerkrankungen, Münster

IKFE Institute for Clinical Research and Development, Mainz

Diabetes Zentrum Neuwied, Neuwied

Zentrum für klinische Studien Dresden, GWT-TUD GmbH, Dresden